Avondale Partners Downgrades SurModics (SRDX) to Underperform, Price Target $7.50
Tweet Send to a Friend
Avondale Partners downgraded SurModics (NASDAQ: SRDX) to Underperform from its previous rating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


